Cargando…
Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
Effective and safe delivery of the CRISPR/Cas9 gene-editing elements remains a challenge. Here we report the development of PEGylated nanoparticles (named P-HNPs) based on the cationic α-helical polypeptide poly(γ-4-((2-(piperidin-1-yl)ethyl)aminomethyl)benzyl-l-glutamate) for the delivery of Cas9 e...
Autores principales: | Wang, Hong-Xia, Song, Ziyuan, Lao, Yeh-Hsing, Xu, Xin, Gong, Jing, Cheng, Du, Chakraborty, Syandan, Park, Ji Sun, Li, Mingqiang, Huang, Dantong, Yin, Lichen, Cheng, Jianjun, Leong, Kam W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948953/ https://www.ncbi.nlm.nih.gov/pubmed/29686087 http://dx.doi.org/10.1073/pnas.1712963115 |
Ejemplares similares
-
HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute
por: Lao, Yeh‐Hsing, et al.
Publicado: (2018) -
Enzyme-mimetic self-catalyzed polymerization of polypeptide helices
por: Song, Ziyuan, et al.
Publicado: (2019) -
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
por: Sinclair, Frazer, et al.
Publicado: (2023) -
A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification
por: Chakraborty, Syandan, et al.
Publicado: (2014) -
Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy
por: Shu, Runzhe, et al.
Publicado: (2023)